|
Market Closed -
Sao Paulo
16:05:46 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 11.51 BRL | +0.70% |
|
+2.31% | -4.00% |
Company Valuation: Dimed S.A. Distribuidora de Medicamentos
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,980 | 1,507 | 1,989 | 1,314 | 1,790 | 1,719 | - | - |
| Change | - | -23.88% | 31.94% | -33.91% | 36.16% | -3.93% | - | - |
| Enterprise Value (EV) 1 | 1,904 | 1,585 | 2,126 | 1,656 | 2,071 | 1,969 | 1,990 | 2,186 |
| Change | - | -16.77% | 34.14% | -22.12% | 25.1% | -4.91% | 1.05% | 9.86% |
| P/E | 25.1x | 17.5x | 21.5x | 12.6x | 14.4x | 9.57x | 7.93x | 6.51x |
| PBR | 1.9x | 1.36x | 1.69x | 1.07x | 1.39x | 1.2x | 1.08x | 0.97x |
| PEG | - | 1.86x | 3.12x | 1x | 0.8x | 0.2x | 0.4x | 0.3x |
| Capitalization / Revenue | 0.61x | 0.38x | 0.45x | 0.27x | 0.32x | 0.27x | 0.24x | 0.21x |
| EV / Revenue | 0.59x | 0.4x | 0.48x | 0.33x | 0.38x | 0.31x | 0.27x | 0.27x |
| EV / EBITDA | 6.7x | 7.81x | 9.12x | 6.29x | 6.48x | 4.92x | 4.31x | 4.06x |
| EV / EBIT | 16.4x | 10.8x | 12.9x | 8.48x | 8.13x | 6.18x | 5.63x | 5.24x |
| EV / FCF | - | - | 11.7x | 16.3x | 5.9x | 21.6x | -142x | 437x |
| FCF Yield | - | - | 8.57% | 6.14% | 16.9% | 4.62% | -0.7% | 0.23% |
| Dividend per Share 2 | - | 0.1431 | 0.2516 | - | - | 0.386 | 0.3939 | 0.4685 |
| Rate of return | - | 1.41% | 1.88% | - | - | 3.35% | 3.42% | 4.07% |
| EPS 2 | 0.53 | 0.58 | 0.62 | 0.7 | 0.83 | 1.203 | 1.452 | 1.767 |
| Distribution rate | - | 24.7% | 40.6% | - | - | 32.1% | 27.1% | 26.5% |
| Net sales 1 | 3,225 | 3,990 | 4,461 | 4,942 | 5,512 | 6,284 | 7,248 | 8,226 |
| EBITDA 1 | 284.3 | 202.8 | 233 | 263.1 | 319.4 | 400 | 461.5 | 538.6 |
| EBIT 1 | 116.1 | 147.1 | 165.1 | 195.3 | 254.7 | 318.5 | 353.3 | 417.5 |
| Net income 1 | 121.6 | 97.7 | 92.9 | 105.5 | 124.6 | 173.3 | 227.8 | 262.5 |
| Net Debt 1 | -75.83 | 77.5 | 137.1 | 341.2 | 281.5 | 250 | 270.8 | 467 |
| Reference price 2 | 13.32 | 10.14 | 13.36 | 8.80 | 11.99 | 11.51 | 11.51 | 11.51 |
| Nbr of stocks (in thousands) | 148,648 | 148,644 | 148,852 | 149,358 | 149,257 | 149,376 | - | - |
| Announcement Date | 3/24/22 | 3/23/23 | 3/14/24 | 3/28/25 | 3/20/26 | - | - | - |
1BRL in Million2BRL
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 9.57x | 0.31x | 4.92x | 3.35% | 333M | ||
| 17.67x | 0.74x | 11.03x | -.--% | 15.73B | ||
| 21.72x | 0.84x | 14.16x | 1.03% | 6.72B | ||
| 16.65x | 0.75x | 7.8x | 2.24% | 6.36B | ||
| 14.95x | 0.98x | 7.06x | 2.83% | 4.32B | ||
| 14.56x | 1.25x | 7.64x | 5.52% | 3.24B | ||
| 14.4x | 0.87x | 6.52x | 4.46% | 3.05B | ||
| 13.55x | 0.55x | 4.41x | 5.1% | 2.99B | ||
| 30.9x | - | - | - | 2.4B | ||
| Average | 17.11x | 0.79x | 7.94x | 3.07% | 5.02B | |
| Weighted average by Cap. | 17.80x | 0.81x | 9.55x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PNVL3 Stock
- Valuation Dimed S.A. Distribuidora de Medicamentos
Select your edition
All financial news and data tailored to specific country editions
















